Sign In
Buy AGL
$82.70
-4.05 (-4.67%)
At Close: Jun 03, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
10:00am, Friday, 29'th Aug 2025
NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
10:00am, Wednesday, 27'th Aug 2025
NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to c
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
11:59am, Monday, 25'th Aug 2025
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are a
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
10:00am, Friday, 22'nd Aug 2025
NEW YORK , Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to c
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
02:13pm, Thursday, 21'st Aug 2025
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are
New Strong Sell Stocks for August 20th
07:25am, Wednesday, 20'th Aug 2025
AGL, CCRN and GOGL have been added to the Zacks Rank #5 (Strong Sell) List on August 20, 2025.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
10:00am, Saturday, 16'th Aug 2025
NEW YORK , Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to c
AGL Energy Limited (AGLNF) Q4 2025 Earnings Call Transcript
03:21am, Wednesday, 13'th Aug 2025
AGL Energy Limited (OTCPK:AGLNF) Q4 2025 Earnings Conference Call August 12, 2025 9:00 PM ET Company Participants Damien Nicks - MD, CEO & Director Gary Brown - Chief Financial Officer James Thompson
agilon health, inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - AGL
03:25am, Tuesday, 12'th Aug 2025
LOS ANGELES , Aug. 12, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of agilon health, inc. ("Agilon" or "the Company") (NYSE: AGL) for vio
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
10:00am, Monday, 11'th Aug 2025
NEW YORK , Aug. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to co
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
12:47pm, Saturday, 09'th Aug 2025
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
06:40pm, Wednesday, 06'th Aug 2025
NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to con
agilon health, inc. (AGL) Q2 2025 Earnings Call Transcript
12:01am, Wednesday, 06'th Aug 2025
agilon health, inc. (NYSE:AGL ) Q2 2025 Earnings Conference Call August 5, 2025 5:30 PM ET Company Participants Evan Smith - Corporate Participant Jeffrey Alan Schwaneke - Executive VP & CFO Ronald Al
Agilon Health downgraded to Neutral from Buy at Citi
06:43pm, Tuesday, 05'th Aug 2025
Citi downgraded Agilon Health to Neutral from Buy with a price target of $1, down from $3 after its Q2 results and pulled guidance. The company's Q2 earnings miss was largely driven by limited risk sc
